Letters by company

Crinetics Pharmaceuticals, Inc.

1 letter discussing CRNX. Everything written about it on this site is on its ticker page.

PenderFund Capital Management Ltd. Pender Alternative Arbitrage Fund Manager’s Commentary The Pender Alternative Arbitrage Fund added merger positions while redeploying capital from completed deals, concentrating on small and mid-cap transactions with simpler structures. It favours mature SPACs trading below trust value and argues that robust deal activity, cash-backed SPAC structures and greater market dispersion support event-driven strategies. July 2026 —